INRS professor developing a glycoconjugate vaccine for melio

The threat from Melioidosis is real. The bacterium that causes this infectious multisymptom illness is resistant to antibiotics, making diagnosis and treatment more complex and resulting in a mortality rate of up to 50%.

Related Keywords

Australia , Ireland , Thailand , India , Canada , Dublin , Brazil , Irish , Canadian , Charles Gauthier , Brad Borlee , Alain Lamarre , Emily Henderson , Colorado State University , University Of Oxford , University College Dublin , Canadian Institutes Of Health Research , Professor Charles Gauthier , Canadian Institutes , Health Research , Professor Gauthier , Professor Siobh , Melioidosis , Vaccine , Antibodies , Bacteria , Immune System , Ortality , Neglected Tropical Disease , Reclinical , Preclinical Testing , Research , Ropical Disease ,